Viscogliosi Brothers Watermark Holdings LLC

01/23/2026 | Press release | Archived content

The Truth About MedTech Investing: Capital & Chaos

In this episode of Healthcare Unscripted, hosts Dr. Chris Leslie, MD and Rob Nathan sit down with Kerem Mavituncalilar for a wide-ranging conversation on what it really takes to build, scale, and sustain innovation in healthcare.

From early-stage MedTech investing to the realities of commercialization, Kerem shares insights on how capital, clinical insight, and execution intersect and where things most often break down. The discussion explores the evolving role of surgeons in innovation, how outcomes and data are shaping decision-making, and why the full patient journey matters more than ever.

This episode goes beyond the pitch deck. It is a candid look at how healthcare companies are built in the real world, the tradeoffs leaders face, and what separates ideas that move the needle from those that never make it to patients.

Whether you are a surgeon, founder, investor, or healthcare leader, this conversation offers practical perspective on navigating complexity, aligning incentives, and driving meaningful impact across care delivery.

Watch or listen to episode 4 now: linktr.ee/healthcareunscripted

Viscogliosi Brothers Watermark Holdings LLC published this content on January 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 18, 2026 at 06:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]